Ole Maywald
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
Papers in ⓘ
-
- Chronic Myeloid Leukemia Treatments 3
- Blood groups and transfusion 2
- Genetics 5
- Hemoglobinopathies and Related Disorders 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Rüdiger Hehlmann (7 shared papers)Jan Hastka (6 shared papers)Andreas Reiter (4 shared papers)Georgia Metzgeroth (7 shared papers)Dieter Buchheidt (2 shared papers)Jean‐François Bergmann (1 shared paper)Eva Lengfelder (1 shared paper)Claudia Schoch (2 shared papers)
- Journals
- Leukemia (3 papers)European Journal Of Haematology (2 papers)Annals of Hematology (2 papers)British Journal of Haematology (1 paper)Cytopathology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ole Maywald
11 papers receiving 206 citations
Peers
Comparison fields: 5 of 46
- Hematology 142
- Genetics 89
- Rheumatology 38
- Nephrology 13
- Pathology and Forensic Medicine 26
Countries citing papers authored by Ole Maywald
This map shows the geographic impact of Ole Maywald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Maywald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Maywald more than expected).
Fields of papers citing papers by Ole Maywald
This network shows the impact of papers produced by Ole Maywald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Maywald. The network helps show where Ole Maywald may publish in the future.
Co-authors
The 25 scholars most cited alongside Ole Maywald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 54 | |
| 2 | 2004 | 51 | |
| 3 | 2005 | 40 | |
| 4 | 2003 | 17 | |
| 5 | 2005 | 17 | |
| 6 | 2003 | 13 | |
| 7 | 2006 | 6 | |
| 8 | 2002 | 4 | |
| 9 | 2006 | 3 | |
| 10 | 2003 | 2 | |
| 11 | 2001 | 2 |
About Ole Maywald
Ole Maywald is a scholar working on Hematology, Genetics, Nephrology, Rheumatology and Pathology and Forensic Medicine, having authored 11 papers that have together received 209 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Renal Diseases and Glomerulopathies (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Blood groups and transfusion (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers) and Erythrocyte Function and Pathophysiology (1 paper). The work is most often cited by research in Hematology (142 citations), Genetics (89 citations), Rheumatology (38 citations), Nephrology (13 citations) and Pathology and Forensic Medicine (26 citations). Ole Maywald has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Rüdiger Hehlmann, Jan Hastka, Andreas Reiter, Georgia Metzgeroth, Dieter Buchheidt, Jean‐François Bergmann, Eva Lengfelder, Claudia Schoch, W. D. Ludwig and Michael Schätz. Their work appears in journals such as Leukemia, European Journal Of Haematology, Annals of Hematology, British Journal of Haematology and Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.